Valuation: Biogen Inc.

Market Cap 30.53B 26.49B 24.81B 22.69B 42.84B 2,908B 43.4B 290B 114B 1,453B 115B 112B 4,836B P/E 2026 *
37.6x
P/E 2027 * 18.2x
Enterprise Value 35.61B 30.9B 28.94B 26.47B 49.97B 3,392B 50.63B 339B 133B 1,695B 134B 131B 5,641B EV / Sales 2026 *
3.42x
EV / Sales 2027 * 3.11x
Free-Float
85.97%
Yield 2026 *
-
Yield 2027 * -
1 day-0.99%
1 week-1.64%
Current month+0.78%
1 month-1.89%
3 months+7.26%
6 months+1.67%
Current year+16.22%
1 week 199.58
Extreme 199.58
212.18
1 month 186.02
Extreme 186.025
218.59
Current year 160.36
Extreme 160.3645
219.72
1 year 127
Extreme 127
219.72
3 years 110.04
Extreme 110.035
278.95
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
09/06/26 Free

Director

1,505 0.0010%
13/02/26 Free

Head of Human Resources

8,025 0.0055%
13/02/26 Free

Executive/Senior Manager

10,560 0.0072%
Change 5-day change 1-year change 3-year change Capi.($)
-0.99%-1.64%+58.13%-24.59% 30.53B
-0.68%+3.54%+37.71%-1.32% 76.75B
-1.83%+3.69%+23.09%+181.53% 50.46B
+1.54%+2.37%-6.31%+23.71% 48.5B
+1.30%+3.35%-50.46%-50.08% 44.14B
-2.45%-4.85%+50.71%+80.29% 24.28B
-3.16%-5.75%+104.38%-46.06% 22.46B
+0.72%+1.39%-7.90%+177.29% 20.04B
+1.13%-5.67%+65.36%+120.26% 16.14B
+0.54%+0.18%+83.63%+165.78% 16.03B
Average -0.36%-0.59%+35.83%+62.68% 34.93B
Weighted average by Cap. -0.34%+0.93%+26.09%+46.70%

Financials

2026 *2027 *
Net sales 10.42B 9.04B 8.47B 7.75B 14.62B 993B 14.82B 99.08B 38.88B 496B 39.13B 38.28B 1,651B 10.62B 9.22B 8.63B 7.9B 14.91B 1,012B 15.1B 101B 39.64B 506B 39.89B 39.03B 1,683B
Net income 953M 827M 774M 708M 1.34B 90.79B 1.35B 9.06B 3.56B 45.36B 3.58B 3.5B 151B 1.9B 1.65B 1.54B 1.41B 2.67B 181B 2.7B 18.06B 7.09B 90.39B 7.13B 6.98B 301B
Net Debt 5.08B 4.41B 4.13B 3.78B 7.13B 484B 7.22B 48.3B 18.96B 242B 19.08B 18.66B 805B 2.57B 2.23B 2.09B 1.91B 3.6B 244B 3.65B 24.4B 9.57B 122B 9.63B 9.43B 407B
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
06/08/26 $204.59 -0.99% 279,520
05/08/26 $206.63 -0.87% 873,781
04/08/26 $208.45 +3.29% 1,205,704
03/08/26 $201.82 -0.56% 940,993
31/07/26 $202.95 -2.40% 1,062,258
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
206.63USD
Average target price
235.32USD
Spread / Average Target
+13.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock